Public Trust and Public Bodies: The Regulation of the Use of Human Tissue for Research in the United Kingdom

International Library of Ethics, Law and Technology

Volumn 8, Issue , 2011, Pages 17-35

  Kent, Julie ^a   ter Meulen, Ruud ^b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Fetal Tissue; National Health Service; Public Trust; Stem Cell Line; Stem Cell Research

Indexed keywords

EID: 85098064996     PISSN: 18750044     EISSN: 18750036     Source Type: Book Series    
DOI: 10.1007/978-94-007-1673-5_2     Document Type: Chapter

References (55)

1. Ashcroft, R., and N. Pfeffer. 2001. “Ethics Behind Closed Doors: Do Research Ethics Committees Need Secrecy?” British Medical Journal 322 (7297): 1294–96.
2. Beeson, D., and A. Lippman. 2006. “Egg Harvesting for Stem Cell Research: Medical Risks and Ethical Problems.” Accessed February 25, 2011. http://www.rbmonline.com edn
3. Bristol Royal Infirmary Inquiry. 2000. Interim Report, Removal and Retention of Human Material: Annex and Annex B. London: Central Office of Information.
4. Bristol Royal Infirmary Inquiry. 2001. Learning from Bristol; the Report of the Public Inquiry into Children’s Heart Surgery at the Bristol Royal Infirmary 1984–1995. London: HSMO.
5. Brown, N., A. Faulkner, J. Kent, and M. Michael. 2006. “Regulating Hybrids: ‘Making a Mess’ and ‘Cleaning Up’ in Tissue Engineering and Transpecies Transplantations.” Social Theory and Health 4: 1–24.
6. Brown, N., and M. Michael. 2004. “Risky Creatures: Institutional Species Boundary Change in Biotechnology Regulation.” Health, Risk and Society 6 (3): 207–22.
7. Busby, H. 2006. “Biobanks, Bioethics and Concepts of Donated Blood in the UK.” Sociology of Health & Illness 28 (6): 850–65.
8. Busby, H. 2010a. “The Meanings of Consent to the Donation of Cord Blood Stem Cells: Perspectives from an Interview-Based Study of a Public Cord Blood Bank in England.” Clinical Ethics 5: 22–27.
9. Busby, H. 2010b. “Trust, Nostalgia and Narrative Accounts of Blood Banking in England in the Twenty First Century Health.” An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 14 (4): 364–382.
10. Capps, B., A. Campbell, and R. ter Meulen. 2008. Access to the UK Biobank Resources: Concepts of the Public Interest and the Public Good. UK: Biobank. Accessed February 25, 2011. http://www.egcukbiobank.org.uk/meetingsandreports/
11. Department of Health. 2001. Governance Arrangements for Research Ethics Committees. London: Department of Health.
12. Department of Health. 2002. Human Bodies, Human Choices: The Law on Human Organs and Tissue in England and Wales – A Consultation Report. London: Department of Health.
13. Department of Health. 2005. NHS Research Governance Framework. London: Department of Health.
14. Department of Health. 2010. Liberating the NHS: Report of the Arms-Length Bodies Review. London.
15. Devaney, S. 2008. “Breaches in Good Regulatory Practice – The HFEA Policy on Compensated Egg Sharing for Stem Cell Research.” Clinical Ethics 3 (1): 20–24.
16. Dickenson, D. 2006. “The Lady Vanishes: What’s Missing Form the Stem Cell Debate.” Bioethical Inquiry 3: 43–54.
17. Dickenson, D. 2007. Property in the Body: Feminist Perspectives. Cambridge: Cambridge University Press.
18. Dixon-Woods, M., E. Angell, R. Ashcroft, and A. Bryman. 2007. “Written Work: The Social Functions of Research Ethics Committee Letters.” Social Science and Medicine 65 (4): 792–802.
19. Eckstein, S. 2007. “Research Ethics Committees.” In Good Clinical, Laboratory and Manufacturing Practices Techniques for the QA Professional, edited by N. Dent and P. Carson, 99–108. Cambridge, UK: The Royal Society of Chemistry.
20. Farrell, A.. 2006. “Is the Gift Still Good? Examining the Politics and Regulation of Blood Safety in the European Union.” Medical Law Review 14 (2): 155–79.
21. Faulkner, A., J. Kent, I. Geesink, and D. Fitzpatrick. 2006. “Purity and the Dangers of Regenerative Medicine: Regulatory Innovation of Human Tissue-Engineered Technology.” Social Science & Medicine 63: 2277–88.
22. Hoeyer, K. 2009. “Tradable Body Parts? How Bone and Recycled Prosthetic Devices Acquire a Price Without Forming a ‘Market’.” BioSocieties 4: 239–56.
23. Hoeyer, K.. 2010. “An Anthropological Analysis of European Union (EU) Health Governance as Biopolitics: The Case of the EU Tissues and Cells Directive.” Social Science & Medicine 70 (12): 1867–73.
24. Human Fertilisation and Embryology Authority. 2006. Donating Eggs for Research: Safeguarding Donors. London: HFEA.
25. Human Fertilisation and Embryology Authority. 2007a. “Hybrids and Chimeras: A Report on the Findings of a Consultation.” Accessed February 25, 2011. http://www.hfea.gov.uk/docs/Hybrids_Report.pdf
26. Human Fertilisation and Embryology Authority. 2007b. Statement on Donating Eggs for Research. London: HFEA, February 21.
27. Human Tissue Authority. 2006. Code of Practice 1: Consent. London: Human Tissue Authority.
28. Human Tissue Authority. 2009a. Code of Practice 1: Consent. London: Human Tissue Authority.
29. Human Tissue Authority. 2009b. Code of Practice 5: Disposal of Human Tissue. London: Human Tissue Authority.
30. Human Tissue Authority. 2009c. Code of Practice 9: Research. London: Human Tissue Authority.
31. Jasanoff, S. 2005. Designs on Nature: Science and Democracy in Europe and the United States. Oxford: Princeton University Press.
32. Kent, J. 2008. “The Fetal Tissue Economy: From the Abortion Clinic to the Stem Cell Laboratory.” Social Science & Medicine 67: 1747.
33. Kent, J. 2009. “Enabling Stem Cell Science in the UK? A Short History of a Regulatory Maze, Beyond Pattison.” Stem Cell Initiative Final Conference, Wellcome Trust, London, May 2009.
34. Kent, J. 2012. Regenerating Bodies: Tissue and Cell Therapies in the 21st Century. Abingdon: Routledge.
35. Mclean, S., A. Campbell, H. Harper, and K. Gutridge. 2005. Scoping Study: Ethical and Practical Concerns Regarding Changes to Human Tissues Legislation. Bristol: University of Bristol; Glasgow: University of Glasgow.
36. Mulkay, M. 1997. The Embryo Research Debate Science and Politics of Reproduction. Cambridge: Cambridge University Press.
37. Nuffield Council on Bioethics. 1995. “Human Tissue Ethical and Legal Issues.” Available at: http://www.nuffieldbioethics.org/sites/default/files/Human%20tissue (accessed 14 March 2011).
38. Opinion Leader. 2009. Impact of Legislation and Human Tissue Authority Regulation on Research. London: Human Tissue Authority.
39. O’neill, O. 2003. “Some Limits of Informed Consent.” Journal of Medical Ethics 29: 4–7.
40. O’reilly, M., M. Dixon-Woods, E. Angell, R. Ashcroft, and A. Bryman. 2009. “Doing Accountability: A Discourse Analysis of Research Ethics Committees’ Letters.” Sociology of Health & Illness 31 (2): 246–61.
41. Parry, S.. 2006. “(Re)constructing Embryos in Stem Cell Research: Exploring the Meaning of Embryos for People Involved in Fertility Treatments.” Social Science and Medicine 62 (10): 2349–59.
42. Pfeffer, N., and J. Kent. 2006. “Consent to the Use of Aborted Fetuses in Stem Cell Research and Therapies.” Clinical Ethics 1 (4): 216–18.
43. Pfeffer, N., and J. Kent. 2007. “Framing Women, Framing the Fetus: how Britain Regulates the Collection and Use of Aborted Fetuses in Stem Cell Research and Therapies.” BioSocieties 2 (4): 429–47.
44. Polkinghorne, J. 1989. Review of the Guidance on the Research Use of Fetuses and Fetal Material. Cm 762. London: HMSO.
45. Roberts, C., and K. Throsby. 2008. “Paid to Share: IVF Patients, Eggs and Stem Cell Research.” Social Science and Medicine 66 (1): 159–69.
46. Royal College of Nursing. 2002. Sensitive Disposal of Fetal Remains. London: Royal College of Nursing.
47. Royal College of Obstetricians and Gynaecologists. 2004. Response to MRC Draft Code of Practice for the UK Stem Cell Bank. London: RCOG.
48. Royal College of Obstetricians and Gynaecologists. 2005. RCOG Ethics Committee Response to the Department of Health Review of the Human Fertilisation and Embryology Act. London: RCOG.
49. Royal College of Obstetricians and Gynaecologists and Royal College of Pathologists. 2001. Fetal and Perinatal Pathology Report of a Joint Working Party. London: RCOG.
50. Royal Liverpool Children’s Inquiry. 2001. Report Ordered by the House of Commons. London: The Stationary Office.
51. Salter, B., and C. Salter. 2007. “Bioethics and the Global Moral Economy: The Cultural Politics of Human Embryonic Stem Cell Science.” Science, Technology & Human Values 32 (5): 554–81.
52. Scheper-Hughes, N. 2006. “Alistair Cooke’s Bones: A Morality tale.” Anthropology Today 22 (6): 10–15.
53. The Academy of Medical Sciences. 2010. Reaping the Rewards: A Vision for UK Medical Science. London: Academy of Medical Sciences. http://www.acmedsci.ac.uk
54. Waldby, C. 2006. “Umbilical Cord Blood: from Social Gift to Venture Capital.” Biosocieties 1: 55–70.
55. Waldby, C., and R. Mitchell. 2006. Tissue Economies: Blood, Organs and Cell Lines in Late Capitalism. Durham: Duke University Press.